Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blood |
RCV001794943 | SCV002033801 | likely pathogenic | Hemochromatosis type 2A | 2021-07-01 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV002034649 | SCV002188469 | pathogenic | not provided | 2023-05-27 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the HJV protein in which other variant(s) (p.Arg385*) have been determined to be pathogenic (PMID: 14982873, 30389309). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1327997). This premature translational stop signal has been observed in individual(s) with hereditary hemochromatosis (PMID: 14982873). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Asp149Thrfs*97) in the HJV gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 278 amino acid(s) of the HJV protein. |